Bellevue Asset Management »

Eagle Ban shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Eagle Ban (EGBN) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Eagle Ban

Tip: Access up to 7 years of quarterly data

All positions including Eagle Ban held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Ban by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $4.9M 55k 88.67

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Eagle Ban

BlackRock
Vanguard Group
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Invesco
Hotchkis and Wiley Capital Management
American Century Companies
Charles Schwab Investment Management
AQR Capital Management
Bank of New York Mellon
Goldman Sachs Group
GAMCO Asset Management
Northern Trust

View all funds holding Eagle Ban